Encephalopathy (Brain Disease)

Autor: Marisa Healy, BSN, RN
Contribuidor de contenido: Katherine Okonak, LSW
Fecha de la última revisión: July 30, 2024

What is Encephalopathy?

Encephalopathy is any brain disease that affects how your brain works. Encephalopathy can be caused by: 

Encephalopathy caused by chemotherapy often happens shortly after getting the medication. It tends to get better over time. Common symptoms are:

  • Insomnia.
  • Anxiety.
  • Agitation.
  • Depression.
  • Drowsiness.
  • Confusion.
  • Headache.

Encephalopathy from radiation therapy may happen when your brain is part of the area being treated. When encephalopathy starts during treatment, it is called “acute onset encephalopathy.” It will often get better over time. Signs of acute radiation encephalopathy are headache, nausea, and vomiting.

Encephalopathy can also happen as a late effect of treatment, starting months to years after treatment has ended. Late-onset radiation encephalopathy is often caused by harm done during the initial radiation therapy. Signs of late-onset encephalopathy are:

  • Memory loss.
  • Confusion.
  • Cognitive dysfunction (how your brain works with the rest of the body).
  • Gait (walking) changes.
  • Urinary incontinence (can’t control your bladder).

These symptoms are often like the signs of the original cancer diagnosis.

How is it treated?

Treatment for encephalopathy depends on what is causing it. Treatment often focuses on supportive care and symptom control. Your care team may suggest medications, changes to your diet, dialysis, surgery, and therapy. 

When should I call my care team?

If you have any symptoms of encephalopathy, call your care team right away. 

Baker M, Markman M, Niu J. Cyclophosphamide-induced severe acute hyponatremic encephalopathy in patients with breast cancer: report of two cases. Case reports in oncology. 2014;7(2):550-4.

Cleveland Clinic. Encephalopathy. 2023.

Le EM, Loghin ME. Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients. Current oncology reports. 2014;16(5):383.

Lyros E, Walter S, Keller I, Papanagiotou P, Fassbender K. Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology. Neurotoxicology. 2014;42:8-11.

National Institute of Neurological Disorders and Stroke. Encephalopathy Information Page. 2019. Found at: https://www.ninds.nih.gov/Disorders/All-Disorders/Encephalopathy-Information-Page

Sawaya R, Radwan W, Hammoud S. Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer. Medical oncology. 2014;31(2):831.

Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. The American journal of gastroenterology. 2013;108(9):1458-63.

Publicaciones de Blog Relacionadas

July 14, 2023

Feeding the Gut

by OncoLink Team

April 19, 2023

Happy Occupational Therapy Month

by OncoLink Team